Medication info
Tenelor M Sustained-release Tablet 10/500 mg

Tenelor M Sustained-release Tablet 10/500 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
Orange oval-shaped sustained-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201469 · Approved 2022.04.06 · Insurance code 663608570

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medication is generally administered once daily with the evening meal. The dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one tablet of this medication 20/1000mg extended-release tablet once daily. Patients taking this medication 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medication should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medication, the dose may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered with a sulfonylurea, reducing the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medication have not been specifically evaluated in patients switched from other antihyperglycemic agents. Because changes may cause fluctuations in blood glucose control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medication whole without splitting, crushing, grinding, or chewing it.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes

View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It particularly enhances blood sugar control effects by combining Teneligliptin and Metformin. If taken consistently, it may help stabilize blood sugar levels. It is prescribed appropriately according to the patient's health condition, so take it with confidence. This medication is effective in improving blood sugar control.

How to take

Adult dose

The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medication is generally administered once daily with the evening meal. The dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one tablet of this medication 20/1000mg extended-release tablet once daily. Patients taking this medication 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medication should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medication, the dose may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered with a sulfonylurea, reducing the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medication have not been specifically evaluated in patients switched from other antihyperglycemic agents. Because changes may cause fluctuations in blood glucose control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medication whole without splitting, crushing, grinding, or chewing it.

Precautions

This medication can very rarely cause a serious condition called lactic acidosis. Lactic acidosis is a dangerous state caused by excessive accumulation of lactic acid in the body, which can threaten life if untreated. Caution should be taken when this medication is taken together with insulin or sulfonylurea medications, as hypoglycemia may occur. Hypoglycemia can lead to dizziness, trembling, and in severe cases, loss of consciousness due to excessively low blood sugar levels. This medication should not be used in patients with moderate to severe renal impairment, heart failure, acute cardiac issues, or severe infections. Additionally, it should be stopped before and after examinations using radiocontrast iodine, and resumed only after confirming normal kidney function. It is also safer not to administer this medication to pregnant women or women who may become pregnant, patients with severely impaired liver function, severe lung disease, or those with very poor nutritional status. During the use of this medication, patients should be well aware of hypoglycemic symptoms, and if such symptoms occur, they should immediately consume foods containing sugar. Furthermore, if severe abdominal pain or vomiting occurs, such as in acute pancreatitis, they should seek medical attention immediately. This medication should have liver and kidney functions regularly checked, especially as elderly individuals are more likely to experience renal function decline, and therefore additional caution is necessary. Alcohol consumption can increase the risk of lactic acidosis, so it is advisable to avoid drinking alcohol while taking this medication. In situations where oral intake is difficult due to surgery or severe infection, this medication should be temporarily discontinued, and resumed only after recovery and confirmation of normal kidney function. This medication can very rarely cause allergic reactions such as bullous pemphigoid, which may cause blisters on the skin, so immediate consultation with a specialist is required if any skin abnormalities occur. Finally, this medication has not been shown to be safe or effective in children, so it is best not to use it.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigus
  • acute pancreatitis
  • dizziness
Show 196 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • appetite loss
  • elevated amylase
  • elevated lipase
  • increased AST(GOT)
  • increased ALT(GPT)
  • increased GGT
  • increased ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • increased CK(CPK)
  • elevated serum potassium concentration
  • fatigue
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremors
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • decreased vision
  • cough
  • pulmonary congestion
  • dyspnea
  • medication overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • reduced neutrophil count
  • abnormal blood glucose
  • increased blood glucose
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral calculi
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • bile duct obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • sensory disturbances
  • hepatic coma
  • sensory impairment
  • sensory loss
  • tension-type headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • positional dizziness
  • muscle weakness
  • lower back pain
  • limb pain
  • lumbar spinal canal stenosis
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramping
  • foot deformity
  • hypertrophic osteoarthritis
  • bursitis
  • spinal osteoarthritis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • gastroenteritis
  • vomiting
  • chronic gastritis
  • upper abdominal pain
  • stomatitis
  • gastrointestinal motility disorders
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • abnormal sputum
  • chronic bronchitis
  • adenoid hypertrophy
  • atherosclerosis
  • hypertension
  • otalgia
  • hearing loss
  • endolymphatic hydrops
  • anemia
  • food allergy
  • pressure ulcer
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina
  • otalgia
  • dizziness
  • iron deficiency anemia
  • food allergy
  • pressure ulcer
  • breast cancer
  • uterine suppuration
  • subcutaneous abscess
  • falls
  • animal bites
  • radial fracture
  • hearing loss
  • endolymphatic hydrops
  • dizziness
  • increased blood creatinine
  • increased blood urea
  • atrial fibrillation
  • hypothyroidism
  • insomnia
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • bile duct obstruction
  • toxic hepatitis
  • chronic cholecystitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion
  • urticaria
  • cataract
  • glaucoma
  • blurred vision
  • age-related macular degeneration

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Orange oval-shaped sustained-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.